INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹-95 Cr | ₹-74 Cr | ₹98 Cr | ₹142 Cr | ₹155 Cr |
What is the latest Consolidated Net Profit of INDOCO REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹-95 Cr |
| Mar2025 | ₹-74 Cr |
| Mar2024 | ₹98 Cr |
| Mar2023 | ₹142 Cr |
| Mar2022 | ₹155 Cr |
How is Consolidated Net Profit of INDOCO REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹-95 Cr | Negative | |
| Mar2025 | ₹-74 Cr | Negative | |
| Mar2024 | ₹98 Cr | -30.78 | |
| Mar2023 | ₹142 Cr | -8.11 | |
| Mar2022 | ₹155 Cr | - | |
Compare Consolidated Net Profit of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,318.6 Cr | 7.7% | 18.1% | 2.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 7.7% |
18.1% |
2.4% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses